A case brought by Australia’s consumer regulator against health insurer NIB Health Funds for allegedly violating consumer protection laws by making changes to its plans without first notifying members will head to trial June 6.
The judge overseeing a case brought by Reckitt Benckiser against Aft Pharmaceuticals over its allegedly deceptive painkiller ads has temporarily blocked Aft from releasing ads that claim its Maxigesic painkiller is stronger than other paracetamol-ibuprofen combination drugs.
Australian Unity will fork over $620,000 in compensation to policy holders after an investigation by the consumer regulator found the health insurer had moved the goal posts by altering dental benefits in annual policies halfway through the year.
Aft Pharmaceuticals has denied claims brought by consumer goods giant Reckitt Benckiser that ads for Aft’s over-the-counter painkiller Maxigesic are misleading and causing harm to Reckitt’s brand.